R
Robert D. Kirkcaldy
Researcher at Centers for Disease Control and Prevention
Publications - 109
Citations - 3904
Robert D. Kirkcaldy is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Gonorrhea & Neisseria gonorrhoeae. The author has an hindex of 32, co-authored 97 publications receiving 3312 citations. Previous affiliations of Robert D. Kirkcaldy include United States Department of Health and Human Services.
Papers
More filters
Update to CDC's sexually transmitted disease treatment guidelines, 2010 : Oral cephalosporins no longer a recommended treatment for gonococcal infections
Robert D. Kirkcaldy,Kimberly A. Workowski,Sarah Kidd,Hillard Weinstock,John R. Papp,David L. Trees,Thomas A. Peterman,Gail Bolan +7 more
TL;DR: CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections, and advises combination therapy with ceftriaxone 250 mg intramuscularly and either azithromycin 1 g orally as a single dose or doxycycline twice daily for 7 days as the most reliably effective treatment for uncomplicated gonorrhea.
Journal ArticleDOI
COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
Journal ArticleDOI
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Robert D. Kirkcaldy,Alesia Harvey,John R. Papp,Carlos del Rio,Olusegun O. Soge,King K. Holmes,Edward W. Hook,Grace Kubin,Stefan Riedel,Jonathan M. Zenilman,Kevin Pettus,Tremeka Sanders,Samera Sharpe,Elizabeth Torrone +13 more
TL;DR: This is the first report to present comprehensive surveillance data from GISP and summarize gonococcal susceptibility over time, as well as underscore the history and public health implications of emerging cephalosporin resistance.
Journal ArticleDOI
Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study
Yonatan H. Grad,Yonatan H. Grad,Robert D. Kirkcaldy,David L. Trees,Janina Dordel,Simon R. Harris,Edward Goldstein,Hillard Weinstock,Julian Parkhill,William P. Hanage,Stephen D. Bentley,Stephen D. Bentley,Marc Lipsitch +12 more
TL;DR: Genomic methods might aid efforts to slow the spread of antibiotic-resistant N gonorrhoeae through augmentation of gonococcal outbreak surveillance and identification of populations that could benefit from increased screening for aymptomatic infections.
Journal Article
Update to CDC's sexually transmitted diseases treatment guidelines, 2010
Carlos del Rio,Geraldine S. Hall,King K. Holmes,Olusegun O. Soge,Edward W. Hook,Robert D. Kirkcaldy,Kimberly A. Workowski,Sarah Kidd,Hillard Weinstock,John R. Papp,David L. Trees,Thomas A. Peterman,Gail Bolan +12 more
TL;DR: In this paper, the authors used data from CDC's Gonococcal Isolate Surveillance Project (GISP) to investigate the susceptibility of cefixime susceptibility among urethral N. gonorrhoeae isolates collected in the United States during 2006-2011 and updated CDC's current recommendations for treatment of gonorrhea.